Young B, etc.,al. Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial. Clin Infect Dis. 2018 Oct 1.
Background:
Antibody titres and vaccine effectiveness decline within six months after influenza vaccination in older adults. Biannual vaccination may be necessary to provide year-round protection in the tropics where influenza circulates throughout the year.
Methods:
Tropical Influenza Control Strategies (TROPICS1) was a single-centre, 1:1 randomised, observer-blinded, active-comparator controlled, superiority study in 200 community-resident adults aged ≥65 years. Participants received standard-dose trivalent inactivated influenza vaccination (IIV3) at enrolment, and either tetanus-diphtheria-pertussis vaccination or IIV3 six months later. Primary outcome was the proportion of participants with haemagglutination-inhibition (HI) geometric mean titre (GMT) ≥1:40 one month after the second vaccination (Month 7). Secondary outcomes included GMTs to Month 12, the incidence of influenza-like illness (ILI), and adverse reactions after vaccination.
Results:
At Month 7, the proportion of participants with a HI tire ≥1:40 against A/H1N1 increased by 21.4% (95% CI 8.6-33.4) in the six-monthly vaccination group. This proportion was not significantly higher for A/H3N2 (4.3, 95% CI -1.1-10.8) or B (2.1, 95% CI -2.0-7.3). Six-monthly vaccination significantly increased GMTs against A/H1N1 and A/H3N2 at Month 7, but not B. Participants receiving repeat IIV3 reported a significantly lower incidence of ILI in the six months after the second vaccination (relative vaccine effectiveness 57.1%, 95% CI 0.6-81.5). The frequency of adverse events was similar after first or second influenza vaccination.
Antibody titres and vaccine effectiveness decline within six months after influenza vaccination in older adults. Biannual vaccination may be necessary to provide year-round protection in the tropics where influenza circulates throughout the year.
Methods:
Tropical Influenza Control Strategies (TROPICS1) was a single-centre, 1:1 randomised, observer-blinded, active-comparator controlled, superiority study in 200 community-resident adults aged ≥65 years. Participants received standard-dose trivalent inactivated influenza vaccination (IIV3) at enrolment, and either tetanus-diphtheria-pertussis vaccination or IIV3 six months later. Primary outcome was the proportion of participants with haemagglutination-inhibition (HI) geometric mean titre (GMT) ≥1:40 one month after the second vaccination (Month 7). Secondary outcomes included GMTs to Month 12, the incidence of influenza-like illness (ILI), and adverse reactions after vaccination.
Results:
At Month 7, the proportion of participants with a HI tire ≥1:40 against A/H1N1 increased by 21.4% (95% CI 8.6-33.4) in the six-monthly vaccination group. This proportion was not significantly higher for A/H3N2 (4.3, 95% CI -1.1-10.8) or B (2.1, 95% CI -2.0-7.3). Six-monthly vaccination significantly increased GMTs against A/H1N1 and A/H3N2 at Month 7, but not B. Participants receiving repeat IIV3 reported a significantly lower incidence of ILI in the six months after the second vaccination (relative vaccine effectiveness 57.1%, 95% CI 0.6-81.5). The frequency of adverse events was similar after first or second influenza vaccination.
See Also:
Latest articles in those days:
- Evolutionary Events Promoted Polymerase Activity of H13N8 Avian Influenza Virus 14 hours ago
- Cross-Species Transmission Potential of H4 Avian Influenza Viruses in China: Epidemiological and Evolutionary Study 14 hours ago
- Wild Bird-Origin H6N2 Influenza Virus Acquires Enhanced Pathogenicity after Single Passage in Mice 14 hours ago
- Genetics of H5N1 and H5N8 High-Pathogenicity Avian Influenza Viruses Isolated in Japan in Winter 2021-2022 14 hours ago
- Avian H6 Influenza Viruses in Vietnamese Live Bird Markets during 2018-2021 14 hours ago
[Go Top] [Close Window]